Clinical Trials
Braintumor Website

There are 4 trials:
Facility: UT, MD Anderson Cancer Center
NCT Trial Name# of Centers

NCT01434602

  Phase I-II Everolimus and Sorafenib in Recurrent High-Grade Gliomas
18

NCT02337491

  Pembrolizumab +/- Bevacizumab for Recurrent GBM
8

NCT01339052

  Phase II Study of BKM120 for Subjects With Recurrent Glioblastoma
7

NCT02852655

  A Pilot Surgical Trial To Evaluate Early Immunologic Pharmacodynamic Parameters For The PD-1 Checkpoint Inhibitor, Pembrolizumab (MK-3475), In Patients With Surgically Accessible Recurrent/Progressive Glioblastoma
6



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2017 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites